Compound MBF-118, a novel PPAR-γ receptor modulator for the treatment of cancer. The compound will start IND enabling studies the second quarter 2018.
Compound MBF-118, a novel PPAR-γ receptor modulator for the treatment of cancer. The compound will start IND enabling studies the second quarter 2018.
Compound MBF-118, a novel PPAR-γ receptor modulator for the treatment of cancer. The compound...
No CommentsCompound MBF-118, a novel PPAR-γ receptor modulator for the treatment of cancer. The compound...
No CommentsCompound MBF-118, a novel PPAR-γ receptor modulator for the treatment of cancer. The compound...
No CommentsCompound MBF-118, a novel PPAR-γ receptor modulator for the treatment of cancer. The compound...
No CommentsCompound MBF-118, a novel PPAR-γ receptor modulator for the treatment of cancer. The compound...
No CommentsCompound MBF-118, a novel PPAR-γ receptor modulator for the treatment of cancer. The compound...
No CommentsCompound MBF-118, a novel PPAR-γ receptor modulator for the treatment of cancer. The compound...
No CommentsCompound MBF-118, a novel PPAR-γ receptor modulator for the treatment of cancer. The compound...
No CommentsCompound MBF-118, a novel PPAR-γ receptor modulator for the treatment of cancer. The compound...
No CommentsTo provide the best experiences, we use technologies such as cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting, or withdrawing consent, may adversely affect certain features and functions.